Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma

Fig. 3

Mean change in average weekly morning PEF. AM ante meridiem (morning), BF budesonide–formoterol, PEF peak expiratory flow, SD standard deviation. Data shown are mean change from baseline on weekly average values. Error bars represent SD. a n = 290 at baseline; dropped to n = 263 by week 12. b n = 284 at baseline; dropped to n = 256 by week 12

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us